SEVER, B. Et Al. 2019. In silico Molecular Docking and ADME Studies of 1 3,4-Thiadiazole Derivatives in Relation to in vitro PON1 Activity. CURRENT COMPUTER-AIDED DRUG DESIGN , vol.15, no.2 , 136-144.

SEVER, B., KÜÇÜKOĞLU, K., NADAROĞLU, H., & ALTINTOP, M. D., (2019). In silico Molecular Docking and ADME Studies of 1 3,4-Thiadiazole Derivatives in Relation to in vitro PON1 Activity. CURRENT COMPUTER-AIDED DRUG DESIGN , vol.15, no.2, 136-144.

SEVER, BELGİN Et Al. "In silico Molecular Docking and ADME Studies of 1 3,4-Thiadiazole Derivatives in Relation to in vitro PON1 Activity," CURRENT COMPUTER-AIDED DRUG DESIGN , vol.15, no.2, 136-144, 2019

SEVER, BELGİN Et Al. "In silico Molecular Docking and ADME Studies of 1 3,4-Thiadiazole Derivatives in Relation to in vitro PON1 Activity." CURRENT COMPUTER-AIDED DRUG DESIGN , vol.15, no.2, pp.136-144, 2019

SEVER, B. Et Al. (2019) . "In silico Molecular Docking and ADME Studies of 1 3,4-Thiadiazole Derivatives in Relation to in vitro PON1 Activity." CURRENT COMPUTER-AIDED DRUG DESIGN , vol.15, no.2, pp.136-144.

@article{article, author={BELGİN SEVER Et Al. }, title={In silico Molecular Docking and ADME Studies of 1 3,4-Thiadiazole Derivatives in Relation to in vitro PON1 Activity}, journal={CURRENT COMPUTER-AIDED DRUG DESIGN}, year=2019, pages={136-144} }